Catherine BARRIERE

Maitre de Conférences
institute
HomeCatherine BARRIERE
barrierec-1-Copie.jpg

BARRIERE
Catherine
Maitre de Conférences
MCF

Publications

15 publications
2022

L1 chimeric transcripts are expressed in healthy brain and their deregulation in glioma follows that of their host locus.

Published on 17 Aug 2022 in Human molecular genetics , vol. 31 - pp 2606-2622

Pinson ME , Court F , Masson A , Renaud Y , Fantini A , Bacoeur-Ouzillou O, Barriere M, Pereira B, Guichet PO, Chautard E, Karayan-Tapon L, Verrelle P, Arnaud P , Vaurs-Barrière C

2021

Widespread overexpression from the four DNA hypermethylated HOX clusters in aggressive (IDHwt) glioma is associated with H3K27me3 depletion and alternative promoter usage.

Published on 30 Aug 2021 in Molecular oncology , vol. 15 - pp 1995-2010

Le Boiteux E , Court F , Guichet PO, Vaurs-Barrière C , Vaillant I , Chautard E, Verrelle P, Costa BM, Karayan-Tapon L, Fogli A , Arnaud P

DNA
Gliome
H3K27me3
HOX
2019

Transcriptional alterations in glioma result primarily from DNA methylation-independent mechanisms.

Published on 30 Oct 2019 in Genome research , vol. 29 - pp 1605-1621

Court F , Le Boiteux E , Fogli A , Müller-Barthélémy M, Vaurs-Barrière C , Chautard E, Pereira B, Biau J, Kemeny JL, Khalil T, Karayan-Tapon L, Verrelle P, Arnaud P

2018

Oxidative stress and mitochondrial dynamics malfunction are linked in Pelizaeus-Merzbacher disease.

Published on 30 Sep 2018 in Brain pathology (Zurich, Switzerland) , vol. 28 - pp 611-630

Ruiz M, Bégou M, Launay N, Ranea-Robles P, Bianchi P, López-Erauskin J, Morató L, Guilera C, Petit B, Vaurs-Barriere C , Guéret-Gonthier C, Bonnet-Dupeyron MN, Fourcade S, Auwerx J, Boespflug-Tanguy O, Pujol A

CLIFinder: identification of LINE-1 chimeric transcripts in RNA-seq data.

Published on 15 Feb 2018 in Bioinformatics (Oxford, England) , vol. 34 - pp 688-690

Pinson ME , Pogorelcnik R , Court F , Arnaud P , Vaurs-Barrière C

2017

Detection of the alternative lengthening of telomeres pathway in malignant gliomas for improved molecular diagnosis.

Published on 30 Nov 2017 in Journal of neuro-oncology , vol. 135 - pp 381-390

Fogli A , Demattei MV, Corset L, Vaurs-Barrière C , Chautard E, Biau J, Kémény JL, Godfraind C, Pereira B, Khalil T, Grandin N , Arnaud P , Charbonneau M , Verrelle P

2016

The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients’ survival.

Published on 01 Mar 2016 in Carcinogenesis , vol. 37 - pp 169-176

Fogli A , Chautard E, Vaurs-Barrière C , Pereira B, Müller-Barthélémy M, Court F , Biau J, Pinto AA, Kémény JL, Khalil T, Karayan-Tapon L, Verrelle P, Costa BM, Arnaud P

2013

Fluorescent mRNA labeling through cytoplasmic FISH.

Published on 30 Dec 2013 in Nature protocols , vol. 8 - pp 2538-47

Gasnier M , Dennis C , Vaurs-Barrière C , Chazaud C

2012

Sjögren-Larsson syndrome: novel mutations in the ALDH3A2 gene in a French cohort.

Published on 15 Jan 2012 in Journal of the neurological sciences , vol. 312 - pp 123-6

Sarret C, Rigal M , Vaurs-Barrière C , Dorboz I, Eymard-Pierre E, Combes P, Giraud G , Wanders RJ, Afenjar A, Francannet C, Boespflug-Tanguy O

Relevance of GJC2 promoter mutation in Pelizaeus-Merzbacher-like disease.

Published on 30 Jan 2012 in Annals of neurology , vol. 71 - pp 146-8

Combes P, Kammoun N, Monnier A, Gonthier-Guéret C, Giraud G , Bertini E, Chahnez T, Fakhfakh F, Boespflug-Tanguy O, Vaurs-Barrière C

2011

Molecular genetic analysis of the PLP1 gene in 38 families with PLP1-related disorders: identification and functional characterization of 11 novel PLP1 mutations.

Published on 16 Jun 2011 in Orphanet journal of rare diseases , vol. 6 - pp 40

Grossi S, Regis S, Biancheri R, Mort M, Lualdi S, Bertini E, Uziel G, Boespflug-Tanguy O, Simonati A, Corsolini F, Demir E, Marchiani V, Percesepe A, Stanzial F, Rossi A, Vaurs-Barrière C , Cooper DN, Filocamo M

Neurodegenerative disorder related to AIMP1/p43 mutation is not a PMLD.

Published on 11 Mar 2011 in American journal of human genetics , vol. 88 - pp 392-3; author reply 393-5

Boespflug-Tanguy O, Aubourg P, Dorboz I, Bégou M, Giraud G , Sarret C, Vaurs-Barrière C

2009

Pelizaeus-Merzbacher-Like disease presentation of MCT8 mutated male subjects.

Published on 30 Jan 2009 in Annals of neurology , vol. 65 - pp 114-8

Vaurs-Barrière C , Deville M, Sarret C, Giraud G , Des Portes V, Prats-Viñas JM, De Michele G, Dan B, Brady AF, Boespflug-Tanguy O, Touraine R

2008

Absence of OLIG2 mutations in patients presenting with a severe Pelizaeus-Merzbacher-like leukodystrophy associated with motor neuron dysfunction.

Published on 05 Jun 2008 in American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics , vol. 147B - pp 538-9

Bonnet-Dupeyron MN, Combes P, Boespflug-Tanguy O, Vaurs-Barrière C

PLP1 splicing abnormalities identified in Pelizaeus-Merzbacher disease and SPG2 fibroblasts are associated with different types of mutations.

Published on 30 Aug 2008 in Human mutation , vol. 29 - pp 1028-36

Bonnet-Dupeyron MN, Combes P, Santander P, Cailloux F, Boespflug-Tanguy O, Vaurs-Barrière C

Contact
Catherine BARRIERE

    logo-europe
    logo-region-auvergne
    logo-cnrs
    logo-uca
    logo-inserm
    iGReD
    Votre navigateur est obsolète

    Pour profiter du site,
    merci de mettre à jour votre navigateur